
Acutus Medical AFIB
Quarterly report 2024-Q3
added 11-14-2024
Country |
|
IPO year |
2020 |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
29.1 M |
Market Cap[1] |
$ 2.62 M |
EBITDA (LTM) |
$ -991 K |
P/E (LTM) |
- |
P/S (LTM) |
0.17 |
EPS (LTM) |
-0.73 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Bruker Corporation
BRKR
|
$ 39.08 | -1.83 % | $ 5.82 K | Nasdaq Global Select Market,SPB | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Cognyte Software Ltd.
CGNT
|
$ 7.79 | 3.73 % | $ 559 M | Nasdaq Global Select Market,SPB | ||
|
AdaptHealth Corp.
AHCO
|
$ 9.41 | -2.39 % | $ 1.27 B | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
CONMED Corporation
CNMD
|
$ 43.34 | -5.35 % | $ 1.35 B | NYSE,SPB | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
FONAR Corporation
FONR
|
$ 18.49 | -0.38 % | $ 121 M | Nasdaq Capital Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
AxoGen
AXGN
|
$ 29.78 | -2.84 % | $ 1.37 B | Nasdaq Capital Market,SPB | ||
|
Apyx Medical Corporation
APYX
|
$ 3.18 | -3.05 % | $ 110 M | Nasdaq Global Select Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Accuray Incorporated
ARAY
|
$ 0.52 | -5.19 % | $ 53.4 M | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.79 | 5.78 % | $ 43 M | Nasdaq Capital Market | ||
|
Align Technology
ALGN
|
$ 182.92 | -3.23 % | $ 13.7 B | Nasdaq Global Select Market,SPB | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Butterfly Network
BFLY
|
$ 3.73 | -3.37 % | $ 790 M | NYSE | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.96 | -3.54 % | $ 148 M | Nasdaq Global Market | ||
|
Abbott Laboratories
ABT
|
$ 113.53 | -0.49 % | $ 198 B | NYSE,SPB | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Boston Scientific Corporation
BSX
|
$ 73.88 | -3.07 % | $ 109 B | NYSE,SPB | ||
|
Helius Medical Technologies
HSDT
|
$ 2.0 | -5.9 % | $ 1.22 M | Nasdaq Capital Market | ||
|
Alphatec Holdings
ATEC
|
$ 13.07 | -3.01 % | $ 1.96 B | Nasdaq Global Select Market | ||
|
Electromed
ELMD
|
$ 23.92 | -0.58 % | $ 202 M | NYSE American | ||
|
InMode Ltd.
INMD
|
$ 13.58 | -0.44 % | $ 878 M | Nasdaq Global Select Market,SPB | ||
|
Edwards Lifesciences Corporation
EW
|
$ 85.42 | -1.99 % | $ 50 B | NYSE,SPB | ||
|
IRIDEX Corporation
IRIX
|
$ 1.45 | 2.84 % | $ 23.4 M | Nasdaq Global Select Market | ||
|
IRadimed Corporation
IRMD
|
$ 104.65 | 0.88 % | $ 1.33 B | Nasdaq Global Select Market | ||
|
Inogen
INGN
|
$ 6.22 | 0.65 % | $ 165 M | Nasdaq Global Select Market,SPB | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Inspire Medical Systems
INSP
|
$ 65.61 | 1.3 % | $ 1.93 B | NYSE,SPB | ||
|
Integra LifeSciences Holdings Corporation
IART
|
$ 10.5 | 0.62 % | $ 809 M | Nasdaq Global Select Market,SPB | ||
|
Integer Holdings Corporation
ITGR
|
$ 86.78 | 0.32 % | $ 3.01 B | NYSE,SPB | ||
|
Aethlon Medical
AEMD
|
$ 1.82 | -2.67 % | $ 2.84 M | Nasdaq Capital Market | ||
|
Avanos Medical
AVNS
|
$ 13.89 | -0.57 % | $ 643 M | NYSE,SPB | ||
|
LENSAR
LNSR
|
$ 11.97 | -0.21 % | $ 138 M | Nasdaq Capital Market | ||
|
Bio-Rad Laboratories
BIO
|
$ 280.82 | 0.26 % | $ 7.92 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.